Reflecting on Concepts Relevant to Contemplating the Relationships Between Glucose–Insulin Perturbations, Nutrition, and Aging

References

• Harman D. Aging; prospects for further increases in the functional life span. Age. 1994;17(4):119–146.
   Google Scholar
• Knight JA. The process and theories of aging. Ann Clin Lab Sci. 1995;25(1):1–12.
   PubMed Web of Science ®Google Scholar
• DeFronzo R. Glucose intolerance and aging. Diabetes Care. 1981;4(4):493–501.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Chen N, Hollenbeck C, Chen YDI. Effect of age on glucose tolerance and glucose uptake in healthy individuals. J Am Geriatr Soc. 1989;37(8):735–740.
   PubMed Web of Science ®Google Scholar
• Broughton DL, Taylor RL. Review: deterioration of glucose tolerance with age: the role of insulin resistance. Age Ageing. 1991;20(3):221–225.
   PubMed Web of Science ®Google Scholar
• Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R. Age as independent determinant of glucose tolerance. Diabetes. 1991;40(1):44–51.
   PubMed Web of Science ®Google Scholar
• Masoro EJ, McCarter RJM, Katz MS, McMahan CA. Dietary restriction alters characteristics of glucose fuel use. J Gerontol. 1992;47(6):B202–B208.
   PubMedGoogle Scholar
• Preuss HG. The insulin system in health and disease (Editorial). J Am Coll Nutr. 1997;16(5):393–394.
   PubMed Web of Science ®Google Scholar
• Preuss HG. Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence. J Am Coll Nutr. 1997;16(5):397–403.
   PubMed Web of Science ®Google Scholar
• Preuss HG. Effects of diets containing different proportions of macronutrients on longevity of normotensive Wistar rats. Ger Nephrol Urol. 1997;781–86.
   PubMedGoogle Scholar
• Preuss HG. Aging: relationship to insulin resistance. Maturity: Canada 1:12–14, 1998.
   Google Scholar
• Preuss HG, Zein M, MacArthy P, Dipette D, Sabnis S, Knapka J. Sugar-induced blood pressure elevations over the lifespan of three substrains of Wistar rats. J Am Coll Nutr. 1998;17(1):36–47.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Bagchi D, Clouatre D. Insulin resistance; a factor in aging. In: Ghen MJ, Corso N, Joiner-Bey H, Klatz R, Dratz A, editors. The advanced guide to longevity medicine. Ghen: Landrum SC; 2001. pp. 239–250.
   Google Scholar
• DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173–194.
   PubMed Web of Science ®Google Scholar
• McCarty MF. Homologous physiological effects of phenformin and chromium picolinate. Med Hypotheses. 1993;41(4):316–334.
   PubMed Web of Science ®Google Scholar
• Reid IR, Evans MC, Cooper GJS, Ames RW, Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol. 1993;265(4 Pt 1):E655–E659.
   PubMedGoogle Scholar
• Buysschaert M, Cauwe F, Jamart J, Brichant C, De Coster P, Magnan A, Donckier J. Proximal femur density in type 1 and 2 diabetic patients. Diabetes Metab. 1992;18(1):32–37.
   Web of Science ®Google Scholar
• Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA. Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J. 1922;12(3):141–146.
   PubMedGoogle Scholar
• Himsworth H. Diabetes mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet. 1936;1:127–130.
   Google Scholar
• Ginsberg H, Kimmerling G, Olefsky JM, Reaven GM. Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes. 1974;23(8):674–678.
   PubMed Web of Science ®Google Scholar
• Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 1996;45(12):1661–1669.
   PubMed Web of Science ®Google Scholar
• Yudkin J. Diet and coronary thrombosis. Hypothesis and fact. Lancet. 1957;270(6987):155–162.
   Google Scholar
• Yudkin J. Dietary factors in arteriosclerosis: sucrose. Lipids. 1978;13(5):370–372.
   PubMed Web of Science ®Google Scholar
• Yudin J, Morland J. Sugar intake and myocardial infarction. Am J Clin Nutr. 1967;20(5):503–506.
   PubMed Web of Science ®Google Scholar
• Yudkin J. Patterns and trends in carbohydrate consumption and their relation to disease. Proc Nutr Soc. 1964;23:149–162.
   PubMed Web of Science ®Google Scholar
• Szanto S, Yudkin J. The effect of dietary sucrose on blood lipids, serum insulin, platelet adhesiveness and body weight in human volunteers. Postgrad Med J. 1969;45(527):602–607.
   PubMed Web of Science ®Google Scholar
• Yudkin J, Szanto SS. Hyperinsulinemia. Br Med J. 1971;1(5744):349.
   PubMedGoogle Scholar
• Yudkin J. Sucrose, coronary heart disease, diabetes, and obesity: do hormones provide a link? Am Heart J. 1988;115(2):493–498.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Ho H, Hoffman BB. Somatostatin inhibition of fructose-induced hypertension. Hypertension. 1989;14(2):117–120.
   PubMed Web of Science ®Google Scholar
• Reiser S, Handler HB, Gardner LB, Hallfrisch JG, Michaelis OE, Prather ES. Isocaloric exchange of dietary starch and sucrose in humans. II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and glucose response to a sucrose load. Am J Clin Nutr. 1979;32(11):2206–2216.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Mrvichin N, Bagchi D, Preuss J, Perricone N, Kaats GR. Importance of fasting blood glucose in screening/tracking over-all health. Orig Intern. 2016;23:13–20.
   Google Scholar
• Preuss HG, Mrvichin N, Bagchi D, Preuss J, Perricone N, Kaats GR. Fasting circulating glucose levels in the non-diabetic range correlate appropriately with many components of the metabolic syndrome. Orig Intern. 2016;23:78–89.
   Google Scholar
• Preuss HG, Mrvichin N, Clouatre D, Bagchi D, Preuss JM, Perricone NV, Swaroop A, Kaats GR. General lack of correlations between individual age and signs of the metabolic syndrome in those with non-diabetic fasting glucose levels. J Am Coll Nutr. 2017;36(7):556–564.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Kaats GR, Mrvichin N, Bagchi D, Swaroop A. Longitudinal examination of links between risk factors for the metabolic syndrome and both age and fasting glucose levels in non-diabetic subjects. J Am Coll Nutr. 2018;13:1–6.
   Google Scholar
• Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulin resistant state. J Cardiovasc Pharmacol. 1990;15:S18–S25.
   PubMed Web of Science ®Google Scholar
• Preuss H. A role for chromium deficiency in the aging process. Reference Review. Women’s Health Alternative Medicine Report. 1999;1:5–6.
   Google Scholar
• Preuss HG, Echard B, Clouatre D, Bagchi D, Perricone NV. Niacin-bound chromium increases life span in Zucker Fatty Rats. J Inorg Biochem. 2011;105(10):1344–1349.
   PubMed Web of Science ®Google Scholar
• Dilman VM, Anisimov VN. Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice. Gerotology. 1980;26:214–246.
   Google Scholar
• Anisimov VN, Semenchenko AV, Yashin AI. Insulin and longevity: antidiabetic biguanides as geroprotectors. Biogerontology. 2003;4(5):297–307.
   PubMed Web of Science ®Google Scholar
• Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, Gomes AP, Ward TM, Minor RK, Blouin MJ, et al. Metformin improves healthspan and lifespan in mice. Nat Commun. 2013;4:2192. doi:10.1038/ncomms3192.
   PubMed Web of Science ®Google Scholar
• Preuss HG. Insulin resistance syndrome: a crucial example where a physiological continuum of risks needs. In: Bagchi D, editor. Nutritional and therapeutic interventions for diabetes and metabolic syndrome. 2nd ed. Amsterdam, Netherlands: Elsevier; 2018.
   Google Scholar
• Sung K-C, Jeong W-S, Wild SH, Byrne CD. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes. Diabetes Care. 2012;35(4):717–722.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Kaats GR. Examining possible causes for age-related blood pressure elevations in 107 females volunteering for a weight loss study. Orig Intern. 2011;18:92–95.
   Google Scholar
• Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman MI, Stravitz RT, Sanyal AJ. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37:1286–1292.
   PubMed Web of Science ®Google Scholar
• Porter SA, Pedley A, Massaro JM, Vasan RS, Hoffman U, Fox CS. Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2013;33(1):139–146.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM. The 2017 clinical practice guideline for high blood pressure. JAMA. 2017;318(21):2073–2074.
   PubMed Web of Science ®Google Scholar
• Carey E, Wieckowska A, Carey WC. Nonalcoholic fatty liver disease. Cleveland Clinic. [last viewed 2017 Dec 12] http://www.clevelandclinicmeded/medicalpubs/diseasemanagement/hepatology/nonalcoholic–fatty-liver-disease/.
   Google Scholar
• Musso G, Gambino R, Bo S, Uberti B, Biroli G, Pagano G, Cassader M. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care. 2008;31(3):562–568.
   PubMed Web of Science ®Google Scholar
• Dong MH, Bettencourt R, Barrett-Connor E, Loomba R. Alanine aminotransferase decreases with age: The Rancho Bernardo Study. PLoS One. 2010;5(12):el14254. Doi:10.1371/journal.pone.0014254
   Web of Science ®Google Scholar
• Dong MH, Bettencourt R, Brenner DA, Barrett-Connor E, Loomba R. Serum levels of alanine aminotransferase decrease with age in longitudinal analysis. Clin Gastroenterol Hepatol. 2012;10:285–290.
   PubMed Web of Science ®Google Scholar
• Davidson MB. The effects of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus. Metabolism. 1979;28(6):688–705.
   PubMed Web of Science ®Google Scholar
• Fink RI, Kolterman O, Griffin J, Olefsky JM. Mechanisms of insulin resistance in aging. J Clin Invest. 1983;71(6):1523–1535.
   PubMed Web of Science ®Google Scholar
• Kreisberg RA. Aging, glucose metabolism, and diabetes: current concepts. Geriatrics. 1987;42(4):67–72.
   PubMed Web of Science ®Google Scholar
• Ryan AS. Insulin resistance with aging: effects of diet and exercise. Sports Med. 2000;30(5):327–346.
   PubMed Web of Science ®Google Scholar
• Darwin C. On the origin of species by means of natural selection. Birmingham, AL: Gryphon Eds, Inc.; 1987, p. 1–501.
   Google Scholar
• Masoro EJ, McCarter RJM, Katz MS, McMahan CA. Dietary restriction alters characteristics of glucose fuel use. J Gerontology. 1992;47:B202–B208.
   PubMedGoogle Scholar
• Preuss HG. The Bitter sweet. New York, NY: Marcell Publishing; 2017, p. 1–116.
   Google Scholar
• Preuss HG, Clouatre D. Potential of diet and dietary supplementation to ameliorate the chronic clinical perturbations of the metabolic syndrome. In: Sinatra S and Houston M, editors. Nutritional and integrative strategies in cardiovascular Medicine. Boca Raton, Florida: CRC press; 2015. pp. 148–178.
   Google Scholar